Hypercalcemia in metastatic disease is mediated through various factors, such as parathyroid hormone-related protein (PTHrP), interleukin-1 (IL-1), IL-6, tumor necrosis factor-alpha (TNF-α), and colony-stimulating factors (CSFs). Here, PTHLH is linked to hypercalcemia disease.